Suppr超能文献

对乙酰氨基酚及其代谢物在婴儿体内的药代动力学

Paracetamol and metabolite pharmacokinetics in infants.

作者信息

van der Marel Caroline D, Anderson Brian J, van Lingen Richard A, Holford Nicholas H G, Pluim Marien A L, Jansman Frank G A, van den Anker John N, Tibboel Dick

机构信息

Department of Paediatric Surgery, Erasmus MC-Sophia, Dr. Molenwaterplein 60, 3016 GJ Rotterdam, The Netherlands.

出版信息

Eur J Clin Pharmacol. 2003 Jul;59(3):243-51. doi: 10.1007/s00228-003-0608-0. Epub 2003 May 22.

Abstract

BACKGROUND

Data concerning metabolism of paracetamol in infants are scant. Previous studies have examined urinary metabolite recovery rates after a single dose of paracetamol in either neonates (<6 weeks) or children (3-9 years). There are no studies investigating infants.

METHODS

Infants ( n=47) undergoing major craniofacial surgery were given paracetamol 19-45 mg/kg 6-, 8-, or 12-hourly as either elixir or suppository formulation for postoperative analgesia, after a loading dose of 33-59 mg/kg rectally during the operation. Serum was assayed for paracetamol concentration in 40 of these infants at 5, 8, 11, 14, 17 and 20 h postoperatively. Urine samples were collected every 3 h for 24 h in 15 of these infants. The clearances of paracetamol to glucuronide and sulphate metabolites as well as the urinary clearance of unmetabolised paracetamol were estimated using non-linear, mixed-effects models.

RESULTS

Mean (+/-SD) age and weight of the patients were 11.8+/-2.5 months and 9.1+/-1.9 kg. Clearances of paracetamol to paracetamol-glucuronide (%CV) and to paracetamol-sulphate were 6.6 (11.5) l/h and 7.5 (11.5) l/h respectively, standardised to a 70-kg person using allometric "1/4 power" models. Glucuronide formation clearance, but not sulphate formation, was related to age and increased with age from a predicted value in a neonate of 2.73 l/h/70 kg to a mature value of 6.6 l/h/70 kg with a maturation half-life of 8.09 months. Urine clearance of paracetamol-glucuronide, paracetamol-sulphate and unchanged paracetamol (%CV) were, respectively, 2.65, 3.03 and 0.55 (28) l/h/70 kg. The urine clearance of unchanged paracetamol and metabolites was related to urine volume flow rate. Clearance attributable to pathways other than these measured in urine was not identifiable. The glucuronide/sulphate formation clearance ratio was 0.69 at 12 months of age. Sulphate metabolism contributed 50% towards paracetamol clearance.

CONCLUSION

Glucuronide formation clearance increases with age in the infant age range but sulphate formation does not. Renal clearance of paracetamol and its metabolites increases with urine flow rate. This and other studies show that paracetamol metabolism to glucuronide appears to be similar in infants and children, but in adults is increased in comparison with children. Oxidative pathways were undetectable in this infant study and may explain, in part, the reduced incidence of hepatotoxicity in infants.

摘要

背景

关于对乙酰氨基酚在婴儿体内代谢的数据很少。以往的研究考察了新生儿(<6周)或儿童(3 - 9岁)单次服用对乙酰氨基酚后的尿代谢产物回收率。尚无针对婴儿的研究。

方法

47例接受重大颅面手术的婴儿,术中直肠给予33 - 59mg/kg的负荷剂量后,术后以酏剂或栓剂形式按19 - 45mg/kg每6、8或12小时给予对乙酰氨基酚用于术后镇痛。其中40例婴儿在术后5、8、11、14、17和20小时测定血清对乙酰氨基酚浓度。15例婴儿每3小时收集一次尿液样本,共收集24小时。使用非线性混合效应模型估计对乙酰氨基酚向葡萄糖醛酸和硫酸盐代谢产物的清除率以及未代谢对乙酰氨基酚的尿清除率。

结果

患者的平均(±标准差)年龄和体重分别为11.8±2.5个月和9.1±1.9kg。使用异速生长“1/4幂”模型将对乙酰氨基酚向对乙酰氨基酚 - 葡萄糖醛酸(%CV)和对乙酰氨基酚 - 硫酸盐的清除率标准化到70kg个体后,分别为6.6(11.5)l/h和7.5(11.5)l/h。葡萄糖醛酸形成清除率与年龄相关,但硫酸盐形成清除率与年龄无关,葡萄糖醛酸形成清除率随年龄从新生儿预测值2.73l/h/70kg增加到成熟值6.6l/h/70kg,成熟半衰期为8.09个月。对乙酰氨基酚 - 葡萄糖醛酸、对乙酰氨基酚 - 硫酸盐和未代谢对乙酰氨基酚的尿清除率(%CV)分别为2.65、3.03和0.55(28)l/h/70kg。未代谢对乙酰氨基酚和代谢产物的尿清除率与尿量流速相关。无法确定尿液中未测定途径的清除率。12个月龄时葡萄糖醛酸/硫酸盐形成清除率比值为0.69。硫酸盐代谢对对乙酰氨基酚清除率的贡献为50%。

结论

在婴儿年龄范围内,葡萄糖醛酸形成清除率随年龄增加而硫酸盐形成清除率不随年龄增加。对乙酰氨基酚及其代谢产物的肾清除率随尿流速增加。本研究及其他研究表明,对乙酰氨基酚在婴儿和儿童体内向葡萄糖醛酸的代谢似乎相似,但与儿童相比,在成人中有所增加。在本婴儿研究中未检测到氧化途径,这可能部分解释了婴儿肝毒性发生率较低的原因。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验